MedTrace Logo

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

NCT00262210 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2005-12-06

No results posted yet for this study

Summary

\* AIMS OF THE STUDY

1. To test if steroid-free chemotherapeutic regimens decrease the risk of HBV reactivation and hepatitis development in HBsAg (+) carriers.
2. To compare the efficacy of steroid-free chemotherapeutic regimens with that of steroid-containing regimens in terms of lymphoma control.
3. To study the change of activity of HBV and other hepatotropic viruses during the course of chemotherapy.

Conditions

  • Non-Hodgkin's Lymphoma

Interventions

DRUG

Cyclophosphamide Epirubicin Etoposide Prednisolone

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Ann-Lii Cheng, Ph.D. · Lymphoma Disease Committee of TCOG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1995-06-30
Completion
1999-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00262210 on ClinicalTrials.gov